Your browser doesn't support javascript.
loading
Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells.
Bosch-Vilaró, Albert; Jacobs, Bart; Pomella, Valentina; Abbasi Asbagh, Layka; Kirkland, Richard; Michel, Joe; Singh, Sharat; Liu, Xinjun; Kim, Phillip; Weitsman, Gregory; Barber, Paul R; Vojnovic, Borivoj; Ng, Tony; Tejpar, Sabine.
Afiliación
  • Bosch-Vilaró A; Laboratory of Molecular Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Jacobs B; Laboratory of Molecular Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Pomella V; Laboratory of Molecular Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Abbasi Asbagh L; Laboratory of Molecular Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Kirkland R; Prometheus Laboratories, San Diego, CA, USA.
  • Michel J; Prometheus Laboratories, San Diego, CA, USA.
  • Singh S; Prometheus Laboratories, San Diego, CA, USA.
  • Liu X; Prometheus Laboratories, San Diego, CA, USA.
  • Kim P; Prometheus Laboratories, San Diego, CA, USA.
  • Weitsman G; Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, King's College London, Guy's Medical School Campus, London, UK.
  • Barber PR; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
  • Vojnovic B; Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, King's College London, Guy's Medical School Campus, London, UK.
  • Ng T; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
  • Tejpar S; Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, King's College London, Guy's Medical School Campus, London, UK.
Oncotarget ; 8(3): 4277-4288, 2017 Jan 17.
Article en En | MEDLINE | ID: mdl-28032592
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinazolinas / Receptor ErbB-2 / Receptor ErbB-3 / Inhibidores de Proteínas Quinasas / Receptores ErbB / Cetuximab Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinazolinas / Receptor ErbB-2 / Receptor ErbB-3 / Inhibidores de Proteínas Quinasas / Receptores ErbB / Cetuximab Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Bélgica